(Q44194910)

30 November 2017

title

Liquid chromatographic method for the determination of ganciclovir and/or acyclovir in human plasma using pulsed amperometric detection (English)

1 reference

30 November 2017

1 reference

3

1 reference

30 November 2017

Yoh Takekuma

2

0 references

author name string

Satoshi Kishino

1

1 reference

30 November 2017

Tsuyoshi Shimamura

4

1 reference

30 November 2017

Hiroyuki Furukawa

5

1 reference

30 November 2017

Satoru Todo

6

1 reference

30 November 2017

Katsumi Miyazaki

7

1 reference

30 November 2017

publication date

1 November 2002

1 reference

Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences

30 November 2017

published in

1 reference

30 November 2017

volume

780

1 reference

30 November 2017

issue

2

1 reference

30 November 2017

page(s)

289-294

1 reference

9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900538-X

7 January 2021

9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine: a new potent and selective antiherpes agent

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900538-X

7 January 2021

Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl)guanine in patients with AIDS and other immunodeficiencies

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900538-X

7 January 2021

Ganciclovir for the treatment and suppression of serious infections caused by cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900538-X

7 January 2021

Ganciclovir therapy in iatrogenically immunosuppressed patients with cytomegalovirus disease

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900538-X

7 January 2021

Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900538-X

7 January 2021

Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900538-X

7 January 2021

Acyclovir: A Decade Later

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900538-X

7 January 2021

Development and validation of a sensitive method for the determination of ganciclovir in human plasma samples by reversed-phase high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900538-X

7 January 2021

Simple reversed-phase high-performance liquid chromatography quantitation of ganciclovir in human serum and urine

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900538-X

7 January 2021

High-performance liquid chromatographic determination of acyclovir in serum

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900538-X

7 January 2021

Foscarnet and ganciclovir pharmacokinetics during concomitant or alternating maintenance therapy for AIDS-related cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900538-X

7 January 2021

Pharmacokinetics of acyclovir in patients undergoing continuous venovenous hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900538-X

7 January 2021

A pharmacokinetic analysis program (multi) for microcomputer

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900538-X

7 January 2021

Sensitivity of clinical isolates of human cytomegalovirus to 9-(1,3-dihydroxy-2-propoxymethyl)guanine

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900538-X

7 January 2021

Evaluation of ganciclovir for cytomegalovirus disease

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900538-X

7 January 2021

Pharmacokinetics and safety of multiple-dose valaciclovir in geriatric volunteers with and without concomitant diuretic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900538-X

7 January 2021

Cytomegalovirus. An unexpected cause of ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900538-X

7 January 2021

Impact of cytomegalovirus infection on organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900538-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900538-X

1 reference

7 January 2021

Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900538-X

7 January 2021

10.1016/S1570-0232(02)00538-X

Identifiers

DOI

1 reference

30 November 2017

1 reference